Oncodna Group News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Oncodna group. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Oncodna Group Today - Breaking & Trending Today

IntegraGen Reports €11.8M Revenues for 2023

IntegraGen Reports €11.8M Revenues for 2023
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

France General , United Kingdom , United States , Virginie Decoster , Institut Pasteur , Bernard Courtieu , Oncodna Group , College Of American Pathologists , American Pathologists , Euronext Growth ,

IntegraGen Reports €5.6m in Revenues for H1 2023 Representing 13% Decrease Compared to H1 2022 and a Cash Position of €4.3m

IntegraGen Reports €5.6m in Revenues for H1 2023 Representing 13% Decrease Compared to H1 2022 and a Cash Position of €4.3m
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United Kingdom , France General , Bernard Courtieu , Belgian Oncodna Group , Oncodna Group , Euronext Growth , Die Experten ,

IntegraGen : reports 2022 annual results with a growth of 16% in revenues and a positive EBITDA.

Increase of activities performed on all sequencing platforms

Positive EBITDA for the second consecutive year despite inflation impact on reagents

. | April 24, 2023 ....

United Kingdom , France General , Institut Pasteur , Gustave Roussy , Institut Curie , Bernard Courtieu , European Society Of Medical Oncology , Oncodna Group , European Society , Medical Oncology , Assistance Publique H , Euronext Growth , Integragen Stock Exchange , Press Release , N Alint Fr0010908723 ,

IntegraGen Reports €12.6m in Revenues for 2022 Representing 16% Growth Compared to 2021 and a Cash Position of €4.5m

Growth supported by the high-throughput genomic sequencing laboratory in Evry Continued sequencing activities on platforms operated on behalf of third parties supported by new clinical research ....

France General , United Kingdom , Bernard Courtieu , Oncodna Group , Euronext Growth , Media Relations ,

Results for the First Half of 2022 - IntegraGen Reports Strong Revenues Growth of 35% With Profitability Improvement

Better profitability despite the inflation Confirmed growth outlook for the 2022 financial year Increase in services provided to platforms operated on behalf of third parties Regulatory ....

France General , United Kingdom , Bernard Courtieu , Oncodna Group , State Guaranteed Loan , Euronext Growth ,